1. Home
  2. BAK vs NNNN Comparison

BAK vs NNNN Comparison

Compare BAK & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Braskem SA ADR

BAK

Braskem SA ADR

HOLD

Current Price

$2.96

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$38.50

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAK
NNNN
Founded
1972
2021
Country
Brazil
Germany
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BAK
NNNN
Price
$2.96
$38.50
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$4.40
N/A
AVG Volume (30 Days)
1.2M
26.4K
Earning Date
11-11-2025
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$13,841,708,237.00
$8,185,146.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
N/A
$721.40
Revenue Growth
N/A
21.95
52 Week Low
$2.32
$5.18
52 Week High
$5.26
$55.65

Technical Indicators

Market Signals
Indicator
BAK
NNNN
Relative Strength Index (RSI) 53.63 70.23
Support Level $2.82 $21.13
Resistance Level $3.11 $29.38
Average True Range (ATR) 0.15 4.90
MACD -0.00 2.09
Stochastic Oscillator 25.58 80.87

Price Performance

Historical Comparison
BAK
NNNN

About BAK Braskem SA ADR

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: